First Turn Management, LLC
DEL MAR, CA · CIK 1993440 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2023 · limited liability company
- Assets managed$900.1m
- Staff4 · 4 in investment roles
- Main clients (by assets)Sovereign wealth funds 90%, Private funds 10%
- Private funds2 (2 hedge) · $36.3m gross assets
- Main officeSolana Beach, CA
- Form ADV · 2026-03-25SEC adviser record
- Legal entityFIRST TURN MANAGEMENT, LLC (US)
$934.7m
reported value
+4.4% vs Q1 2026
31positions
53.6%in top 10
6 new
13 added
11 reduced
8 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| REVOLUTION MEDICINES INC RVMD | $77.8m8.32% | Reduced -53.1k |
| ABIVAX SA ABVX | $65.3m6.98% | Added +24.0k |
| AXSOME THERAPEUTICS INC AXSM | $53.5m5.72% | Added +29.6k |
| ENLIVEN THERAPEUTICS INC ELVN | $48.4m5.18% | Added +330.5k |
| BRIDGEBIO PHARMA INC BBIO | $47.2m5.05% | Reduced -62.4k |
| ROIVANT SCIENCES LTD ROIV | $47.1m5.04% | Added +140.9k |
| UNITED THERAPEUTICS CORP DEL UTHR | $46.0m4.92% | Reduced -19.8k |
| CYTOKINETICS INC CYTK | $44.9m4.81% | Added +243.7k |
| XENON PHARMACEUTICALS INC XENE | $36.2m3.88% | Reduced -186.6k |
| CELCUITY INC CELC | $34.4m3.68% | Added +118.5k |
| VIRIDIAN THERAPEUTICS INC VRDN | $30.7m3.28% | Added +758.7k |
| INSMED INC INSM | $28.1m3.01% | Added +15.4k |
| UNIQURE NV QURE | $28.0m3.00% | Reduced -6.6k |
| ASCENDIS PHARMA A/S ASND | $28.0m2.99% | New |
| PRAXIS PRECISION MEDICINES I PRAX | $28.0m2.99% | Added +41.1k |
| DIANTHUS THERAPEUTICS INC DNTH | $27.9m2.98% | Added +64.8k |
| VAXCYTE INC PCVX | $25.8m2.76% | New |
| MIRUM PHARMACEUTICALS INC MIRM | $25.5m2.73% | Reduced -182.4k |
| PALVELLA THERAPEUTICS INC NE PVLA | $23.9m2.56% | Added +8.4k |
| COGENT BIOSCIENCES INC COGT | $23.3m2.49% | Reduced -345.1k |
| ERASCA INC ERAS | $22.4m2.39% | Added +354.1k |
| ORIC PHARMACEUTICALS INC ORIC | $21.8m2.34% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $19.7m2.11% | Added +24.2k |
| APOGEE THERAPEUTICS INC COM | $18.4m1.97% | Reduced -374.9k |
| RHYTHM PHARMACEUTICALS INC RYTM | $17.1m1.83% | New |
| INHIBRX BIOSCIENCES INC INBX | $15.6m1.67% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $14.9m1.60% | Reduced -175.2k |
| ORUKA THERAPEUTICS INC ORKA | $14.8m1.58% | New |
| KYMERA THERAPEUTICS INC KYMR | $11.8m1.26% | Reduced -152.1k |
| SIONNA THERAPEUTICS INC SION | $4.9m0.52% | New |
| NUVALENT INC COM | $3.2m0.35% | Reduced -344.0k |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| IDEAYA BIOSCIENCES INC IDYA | $29.1m873.8k shares |
| ASCENDIS PHARMA A/S | $17.5m76.3k shares |
| FULCRUM THERAPEUTICS INC FULC | $17.3m2.3m shares |
| TERNS PHARMACEUTICALS INC | $17.2m326.7k shares |
| VERA THERAPEUTICS INC VERA | $17.0m422.0k shares |
| NATERA INC NTRA | $16.2m81.1k shares |
| OLEMA PHARMACEUTICALS INC OLMA | $11.5m768.7k shares |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $5.9m315.6k shares |